Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2009

Open Access 01-12-2009 | Case report

Expression of tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase-3 in proliferated synovium in a patient with synovitis-acne-pustulosis-hyperostosis-osteitis syndrome: a case report

Authors: Koichiro Komiya, Harumoto Yamada, Nobuki Terada, Yoshikazu Mizoguchi, Mitsuko Yamada, Masashi Suzuki, Shinichi Kato

Published in: Journal of Medical Case Reports | Issue 1/2009

Login to get access

Abstract

Introduction

Synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome is a rare disorder. The etiology remains unknown and the treatment is still empirical. Synovitis is one of the major manifestations, but information on histopathological features is still lacking. In this case, we investigated the histopathological features of SAPHO syndrome synovitis.

Case presentation

We present the case of a 53-year-old Japanese woman with SAPHO syndrome accompanied by marked knee synovitis and palmoplantar pustulosis. We found abundant sterile joint fluid in the right knee, and a blood test showed abnormally high values of C-reactive protein (17.26 mg/dl) and matrix metalloproteinase-3 (800 ng/ml). Arthroscopic surgery revealed marked proliferation of villous synovial tissues similar to rheumatoid arthritis and standard microscopic findings were also similar to rheumatoid arthritis. Furthermore, for the first time, we demonstrated by immunohistochemistry the expression of tumor necrosis factor-alpha (TNF-α) converting enzyme, TNF-α and matrix metalloproteinase-3 in the proliferated synovial lining cells. After arthroscopic synovectomy, her knee symptoms immediately diminished and laboratory data (matrix metalloproteinase-3 and C-reactive protein) normalized within 2 weeks of surgery.

Conclusion

We demonstrate the expression of TNF-α converting enzyme, TNF-α and matrix metalloproteinase-3 in SAPHO syndrome synovitis for the first time and also show, both macro- and microscopically, the similarity between SAPHO syndrome and rheumatoid arthritis synovitis. These new findings support the recently reported successful treatment of SAPHO syndrome with antirheumatic drugs, especially with anti-TNF-α agents.
Literature
1.
go back to reference Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A: Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases. Rev Rhum Mal Osteoartic. 1987, 54: 187-196.PubMed Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A: Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases. Rev Rhum Mal Osteoartic. 1987, 54: 187-196.PubMed
2.
go back to reference Petros K, Dimitrios P, Christos K: Successful treatment of SAPHO syndrome with zoledronic acid. Arthritis Rheum. 2004, 50: 2970-2973. 10.1002/art.20464.CrossRef Petros K, Dimitrios P, Christos K: Successful treatment of SAPHO syndrome with zoledronic acid. Arthritis Rheum. 2004, 50: 2970-2973. 10.1002/art.20464.CrossRef
3.
go back to reference Wagner AD, Andresen J, Jendro MC, Hulsemann JL, Zeidler H: Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum. 2002, 46: 1965-1968. 10.1002/art.10539.CrossRefPubMed Wagner AD, Andresen J, Jendro MC, Hulsemann JL, Zeidler H: Sustained response to tumor necrosis factor alpha-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum. 2002, 46: 1965-1968. 10.1002/art.10539.CrossRefPubMed
4.
go back to reference Olivieri I, Padula A, Ciancio G, Salvarani C, Niccoli L, Cantini F: Successful treatment of SAPHO syndrome with infliximab: report of two cases. Ann Rheum Dis. 2002, 61: 375-376. 10.1136/ard.61.4.375.CrossRefPubMedPubMedCentral Olivieri I, Padula A, Ciancio G, Salvarani C, Niccoli L, Cantini F: Successful treatment of SAPHO syndrome with infliximab: report of two cases. Ann Rheum Dis. 2002, 61: 375-376. 10.1136/ard.61.4.375.CrossRefPubMedPubMedCentral
5.
go back to reference Massara A, Cavazzini PL, Trotta F: In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology. 2006, 45: 730-733. 10.1093/rheumatology/kei221.CrossRefPubMed Massara A, Cavazzini PL, Trotta F: In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology. 2006, 45: 730-733. 10.1093/rheumatology/kei221.CrossRefPubMed
6.
go back to reference Iqbal M, Kolodney MS: Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab. J Am Acad Dermatol. 2005, 52: S118-S120. 10.1016/j.jaad.2004.09.006.CrossRefPubMed Iqbal M, Kolodney MS: Acne fulminans with synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab. J Am Acad Dermatol. 2005, 52: S118-S120. 10.1016/j.jaad.2004.09.006.CrossRefPubMed
7.
go back to reference Sabugo F, Liberman C, Niedmann JP, Cuchacovich M: Infliximab can induce a prolonged clinical remission and a decrease in thyroid hormonal requirements in a patient with SAPHO syndrome and hypothyroidism. Clin Rheumatol. 2008, 27: 533-535. 10.1007/s10067-007-0767-y.CrossRefPubMed Sabugo F, Liberman C, Niedmann JP, Cuchacovich M: Infliximab can induce a prolonged clinical remission and a decrease in thyroid hormonal requirements in a patient with SAPHO syndrome and hypothyroidism. Clin Rheumatol. 2008, 27: 533-535. 10.1007/s10067-007-0767-y.CrossRefPubMed
8.
go back to reference Okada Y: Proteinases and matrix degradation. In Kelley’s Textbook of Rheumatology. 7th edition. Edited by Harris E Jr, Budd R, Firestein GS, Genovese MC, Sargent JS, Ruddy S, Sledge C. Philadelphia, PA: Elsevier Saunders; 2004:63-81. Okada Y: Proteinases and matrix degradation. In Kelley’s Textbook of Rheumatology. 7th edition. Edited by Harris E Jr, Budd R, Firestein GS, Genovese MC, Sargent JS, Ruddy S, Sledge C. Philadelphia, PA: Elsevier Saunders; 2004:63-81.
9.
go back to reference Moss ML, Jin SL, Becherer JD, Bickett DM, Burkhart W, Chen WJ, Hassler D, Leesnitzer MT, McGeehan G, Milla M, Moyer M, Rocque W, Seaton T, Schoenen F, Warner J, Willard D: Structural features and biochemical properties of TNF-alpha converting enzyme (TACE). J Neuroimmunol. 1997, 72: 127-129. 10.1016/S0165-5728(96)00180-4.CrossRefPubMed Moss ML, Jin SL, Becherer JD, Bickett DM, Burkhart W, Chen WJ, Hassler D, Leesnitzer MT, McGeehan G, Milla M, Moyer M, Rocque W, Seaton T, Schoenen F, Warner J, Willard D: Structural features and biochemical properties of TNF-alpha converting enzyme (TACE). J Neuroimmunol. 1997, 72: 127-129. 10.1016/S0165-5728(96)00180-4.CrossRefPubMed
Metadata
Title
Expression of tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase-3 in proliferated synovium in a patient with synovitis-acne-pustulosis-hyperostosis-osteitis syndrome: a case report
Authors
Koichiro Komiya
Harumoto Yamada
Nobuki Terada
Yoshikazu Mizoguchi
Mitsuko Yamada
Masashi Suzuki
Shinichi Kato
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2009
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.4076/1752-1947-3-9123

Other articles of this Issue 1/2009

Journal of Medical Case Reports 1/2009 Go to the issue